News: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,481.50GBp
12:09pm EDT
Price Change (% chg)

-73.50p (-4.73%)
Prev Close
1,555.00p
Open
1,556.00p
Day's High
1,560.00p
Day's Low
1,447.50p
Volume
22,930,954
Avg. Vol
7,250,656
52-wk High
1,733.00p
52-wk Low
1,447.50p

Search Stocks
Select another date:

BREAKINGVIEWS-GSK trapped in Big Pharma's strategic bind

(The author is a Reuters Breakingviews columnist. The opinions expressed are his own.)

UK fraud office liaising with China on GSK bribery case

LONDON - Britain's fraud office is working with authorities in China in a first for such Anglo-Chinese cooperation as it carries out its own investigation into alleged corruption at drugmaker GlaxoSmithKline .

GSK clips wings of UK's FTSE after warning

* Strong figures from Capita, BHP Billiton keep index afloat

UPDATE 3-GlaxoSmithKline warns on profits as lung drug sales flag

* Shares as much as 6.9 pct, biggest daily fall since 2008 (Adds further CEO, fund manager and analyst comment)

GSK clips wings of UK's FTSE after warning

* Strong figures from Capita, BHP Billiton keep index afloat

GSK CEO says significant interest in auction of mature drugs

LONDON - GlaxoSmithKline has seen "very significant" interest from mid-sized pharmaceutical companies and private equity firms in acquiring a range of older drugs that it plans to divest, the drugmaker's chief executive said on Wednesday.

GSK CEO says significant interest in auction of mature drugs

LONDON, July 23 - GlaxoSmithKline has seen "very significant" interest from mid-sized pharmaceutical companies and private equity firms in acquiring a range of older drugs that it plans to divest, the drugmaker's chief executive said on Wednesday.

Weak lung drug sales and strong pound hit GlaxoSmithKline

LONDON, July 23 - GlaxoSmithKline's sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.

Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

LONDON/MUMBAI - Indian generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline (GSK) , five sources familiar with the matter said.

China to hold public trial of foreign couple who worked for GSK

BEIJING - China will publicly prosecute a foreign couple linked to drugmaker GlaxoSmithKline Plc GSK.L. on charges of illegally obtaining private information, state media said.

Select another date:
Search Stocks